<DOC>
	<DOCNO>NCT02313610</DOCNO>
	<brief_summary>The purpose study assess efficacy safety Chinese medicine Qinbudan Patients Receiving Standard Combination Therapy Retreatment Pulmonary Tuberculosis .</brief_summary>
	<brief_title>Efficacy Safety Qinbudan Adjunct Therapy Retreatment Pulmonary Tuberculosis</brief_title>
	<detailed_description>Retreatment tuberculosis involve management entity diverse relapse , failure , treatment default , poor patient adherence previous treatment . The emergence condition selection resistance ( failure partial abandonment ) matter great concern . The current chemotherapy primary intervention , long-term drug combination therapy often lead adverse reaction . The purpose study explore role Chinese medicine Qinbudan Patients initially sputum smear positive culture-positive treat previously pulmonary tuberculosis .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Pulmonary</mesh_term>
	<criteria>Patients initially sputum smear positive ( least two smear `` 1+ '' least smear `` 2+ '' ) culturepositive pulmonary tuberculosis treat previously Aged 18 65 year age Patients willing give write informed consent Participation another clinical trial 1 month prior study entry Female patient lactation period , pregnancy plan get pregnant trial Patients allergic therapeutic medicine Patients severe primary disease cancer , cardiovascular system , digestive system , kidney hematopoietic system diseases Patients coinfected HIV , hepatitis B hepatitis C Patients mental illness , acrasia Abnormal liver function combine underlying liver disease ( fatty liver , alcoholic liver ) Patients diabetes , Plasma glucose poorly control undertaking Patients auditory dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Retreatment Pulmonary Tuberculosis , Qinbudan ,</keyword>
</DOC>